These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2219958)

  • 1. Disposition of ampiroxicam, a prodrug of piroxicam, in man.
    Falkner FC; Twomey TM; Borgers AP; Garg D; Weidler D; Gerber N; Browder IW
    Xenobiotica; 1990 Jun; 20(6):645-52. PubMed ID: 2219958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ampiroxicam, an anti-inflammatory agent which is a prodrug of piroxicam.
    Carty TJ; Marfat A; Moore PF; Falkner FC; Twomey TM; Weissman A
    Agents Actions; 1993 Jul; 39(3-4):157-65. PubMed ID: 8304243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.
    Olkkola KT; Brunetto AV; Mattila MJ
    Clin Pharmacokinet; 1994 Feb; 26(2):107-20. PubMed ID: 8162655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of piroxicam in man.
    Hobbs DC
    Eur J Rheumatol Inflamm; 1983; 6(1):46-55. PubMed ID: 6861813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of droxicam in rat and dog.
    Esteve A; Martínez L; Roser R; Sagarra R
    Methods Find Exp Clin Pharmacol; 1986 Jul; 8(7):423-9. PubMed ID: 3762266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supermolecular inclusion of piroxicam with beta-cyclodextrin: pharmacokinetic properties in man.
    Woodcock BG; Acerbi D; Merz PG; Rietbrock S; Rietbrock N
    Eur J Rheumatol Inflamm; 1993; 12(4):12-28. PubMed ID: 7805700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of age on piroxicam disposition in rheumatoid arthritis.
    Blocka KL; Richardson CJ; Wallace SM; Ross SG; Verbeeck RK
    J Rheumatol; 1988; 15(5):757-63. PubMed ID: 3172091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of piroxicam: new aspects.
    Fenner H
    Eur J Rheumatol Inflamm; 1987; 8(1):42-8. PubMed ID: 3622592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of activated charcoal on the bioavailability of piroxicam in man.
    Laufen H; Leitold M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):48-52. PubMed ID: 3957490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetic study of piroxicam in healthy man after administration of a single dose equal to 20 mg, by the oral route].
    Fourtillan JB; Dubourg D
    Therapie; 1983; 38(2):163-70. PubMed ID: 6636023
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetic drug interactions between ampiroxicam and sulfaphenazole in rats.
    Ogiso T; Iwaki M; Tanaka H; Kobayashi E; Tanino T; Sawada A; Uno S
    Biol Pharm Bull; 1999 Feb; 22(2):191-6. PubMed ID: 10077440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic fate and pharmacokinetics of the acyclovir prodrug valaciclovir in cynomolgus monkeys.
    de Miranda P; Burnette TC
    Drug Metab Dispos; 1994; 22(1):55-9. PubMed ID: 8149890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Frequency of administration of nonsteroidal antirheumatic agents with a long biological half-life. A clinical trial with piroxicam].
    Pavelka K
    Fysiatr Revmatol Vestn; 1984 Feb; 62(1):18-25. PubMed ID: 6365712
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetic profile of droxicam.
    Martínez L; Sánchez J
    Eur J Rheumatol Inflamm; 1991; 11(4):10-4. PubMed ID: 1365484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piroxicam pharmacokinetics in man: aspirin and antacid interaction studies.
    Hobbs DC; Twomey TM
    J Clin Pharmacol; 1979; 19(5-6):270-81. PubMed ID: 89124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of cimetidine on the pharmacokinetics of piroxicam in rat and man.
    Said SA; Foda AM
    Arzneimittelforschung; 1989 Jul; 39(7):790-2. PubMed ID: 2783182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic study on piroxicam at the steady-state in elderly subjects and younger adults after administration of piroxicam beta-cyclodextrin.
    Acerbi D; Bonati C; Boscarino G; Bufalino L; Cesari F; D'Ambrosio E; Mansanti P; Scali G
    Int J Clin Pharmacol Res; 1988; 8(3):175-80. PubMed ID: 3403105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Onset of effect of isoxicam and piroxicam. A double-blind parallel study].
    Bara S; Wagenhäuser FJ
    Fortschr Med; 1985 Jan; 103(4):73-6. PubMed ID: 3972324
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential property of antigenic characterization between piroxicam and ampiroxicam in contact hypersensitivity.
    Sasaki T; Tokuyama S; Shimizu H; Kawada H; Soh I; Sueki H; Iijima M; Yamamoto T; Kuroiwa Y
    Res Commun Mol Pathol Pharmacol; 1999; 105(1-2):147-54. PubMed ID: 10850378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of piroxicam, a new nonsteroidal anti-inflammatory agent, under fasting and postprandial states in man.
    Ishizaki T; Nomura T; Abe T
    J Pharmacokinet Biopharm; 1979 Aug; 7(4):369-81. PubMed ID: 512843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.